Hearing-Aid Earbuds: The OTC Promise vs the Fitting Reality

The regulatory change that made this whole category possible happened in the United States in 2022, when the FDA finalised a rule allowing hearing aids for mild-to-moderate hearing loss to be sold over the counter, without an audiologist’s exam or a prescription. The promise that followed, from companies like Jabra with its Enhance line and Sony licensing Bose’s hearing-aid research into the CRE series, was straightforward: clinic-grade correction for a fraction of the price and none of the appointment friction. That promise is real for the specific population it targets, and it comes with a fitting-accuracy gap against a properly audiologist-fitted device that the marketing around this category tends to undersell.

Who this category is actually for

Every OTC hearing aid on the market is explicitly restricted, by the same FDA rule that created the category, to adults with self-perceived mild-to-moderate hearing loss — not the more severe losses that a full clinical hearing aid, fitted after a proper audiogram, is built to address. That’s not a marketing caveat, it’s the regulatory boundary of the entire product category, and it matters because the earbud-like form factor and consumer branding of devices like Jabra’s Enhance Select or Sony’s CRE-C10 can read as a general-purpose hearing solution to a buyer who hasn’t had their hearing loss properly measured. Someone with genuinely moderate-to-severe or profile-specific hearing loss — a sharp high-frequency notch from noise exposure, say, rather than the more even age-related decline these devices are tuned for — is the buyer this category is least likely to serve well, and no amount of in-app self-test sophistication substitutes for an actual audiogram in catching that distinction.

The self-fitting test: genuinely clever, honestly limited

The technical achievement here is real and worth taking seriously. Jabra’s Enhance devices and Sony’s CRE line both run an in-app hearing test — typically a series of tones at different frequencies and volumes, answered through the phone — that builds a personalised amplification profile without a booth or an audiologist present. Independent reviews and audiology commentary broadly credit this self-fitting process with getting meaningfully close to a professionally fitted baseline for straightforward, symmetric, age-related hearing loss, which is exactly the population the FDA rule targets. Where it measurably falls short, per that same independent commentary, is anything asymmetric between the two ears, anything with an unusual frequency-response shape, or anyone who finds the self-test itself confusing to complete accurately — a self-administered hearing test is only as good as the person taking it, in a way a trained audiologist administering the same test in a quiet booth isn’t. Ambient noise during the self-test is the most common reported source of error — a test taken in a normal living room rather than a genuinely quiet space skews the resulting profile, and neither Jabra’s nor Sony’s app can fully control for a wearer’s actual test environment the way a soundproofed clinical booth does.

Materials and build: genuinely earbud-shaped, genuinely different internals

This is where the “gizmo” framing earns its keep, because these devices look almost identical to true-wireless earbuds and are engineered very differently underneath the shell. A conventional earbud’s driver is optimised for full-range music reproduction; a hearing-aid earbud’s amplifier and receiver are tuned instead for speech-frequency clarity and feedback suppression, with far more processing headroom dedicated to preventing the whistling feedback loop that happens when amplified sound leaks back into the device’s own microphone — a problem music earbuds simply don’t have to solve. Battery compartments on several devices in this category use disposable zinc-air cells rather than rechargeable lithium, a deliberate choice trading convenience for a longer, more predictable runtime and avoiding the battery-degradation curve that affects rechargeable true-wireless earbuds over a couple of years of ownership; Sony’s CRE line, by contrast, uses a rechargeable design closer to a conventional earbud case, a legitimate different trade favouring daily convenience over runtime ceiling. The shells themselves run smaller and lighter than most true-wireless earbuds, since all-day wear for twelve-plus hours rather than a couple of listening sessions is the actual use case, and that size constraint limits how much battery or processing headroom a given model can carry compared with a music-first earbud of similar external dimensions.

Where the OTC price actually lands

The headline promise of the category is the price gap against a traditional prescription hearing aid, and it’s a real gap rather than a marketing exaggeration — OTC devices in this category have launched at a small fraction of what a pair of prescription hearing aids typically costs once a full audiologist fitting and follow-up appointments are included in that traditional price. That comparison is honest as far as it goes, but it compares a self-fitted device against a fully serviced clinical product rather than like-for-like hardware, and the price difference reflects the removed service as much as any pure hardware saving. Ongoing costs differ by model too: a device using disposable zinc-air cells carries a small but real recurring battery cost a rechargeable design doesn’t, worth pricing across a year of ownership rather than judging on the sticker price alone.

The case against, made plainly

The most honest criticism of this category targets the risk of self-diagnosis replacing an actual hearing assessment; the hardware itself, by most independent accounts, does what it’s built to do for its intended population. Hearing loss can be a symptom of conditions an audiologist or GP would catch and an app-based self-test won’t, and the ease of buying an OTC device without any clinical checkpoint means some buyers will use amplification to paper over a problem that needed a different kind of attention first. A second, smaller complaint that recurs in independent reviews is Bluetooth and app reliability across both major platforms — hearing devices need a rock-solid, low-latency connection for real-time amplification, and several OTC entrants have had reported pairing or app-stability issues that a conventional earbud’s more mature Bluetooth stack rarely suffers from, a gap that should close as the category matures but is a real friction point for early adopters today. Firmware updates delivered over the same Bluetooth connection have, in most reported cases, steadily improved this over successive app releases, which is the honest argument for buying current-generation hardware in this category rather than a superseded first-generation model even at a discount.

Battery and comfort over a full waking day

The all-day nature of this category changes what “battery life” and “comfort” mean compared with a music earbud, and it’s worth treating separately from a conventional earbud review. A twelve-hour-plus wear expectation, rather than a couple of hours of music at a time, is the actual design brief, which is why zinc-air disposable cells remain common in this category despite rechargeable lithium’s convenience elsewhere in consumer audio: a zinc-air cell’s flatter, more predictable discharge curve over a long single session matters more here than fast-charge convenience, and running out mid-afternoon is a far more disruptive failure for a hearing aid than for a music earbud. Comfort follows the same all-day logic — these shells are shaped for a stable, low-fatigue fit that can be forgotten about for hours rather than the deeper insertion or larger shell some premium noise-cancelling earbuds use to maximise isolation, since isolating the wearer from ambient sound is precisely the opposite of what a hearing aid is for. Independent long-term wearer reports consistently flag the open or vented fit style common to this category as the more comfortable choice for full-day wear, at the cost of the tighter seal a closed earbud tip would give for pure amplification efficiency.

The follow-up care gap

A clinically fitted hearing aid comes with scheduled follow-up appointments where an audiologist re-checks the fit and adjusts the profile as a wearer’s hearing or preferences change — a service layer that’s genuinely valuable and genuinely absent from a self-fitted OTC purchase. Some OTC brands, Jabra’s Enhance line among them, have partly answered this by offering remote support from licensed hearing professionals as a paid or bundled add-on rather than leaving the buyer entirely to the self-test, which narrows but doesn’t close the gap against full clinical follow-up care. A buyer choosing a bare, no-support OTC device over one of these remote-care options should understand that trade explicitly: the lower price also buys less ongoing support if the initial self-fit needs adjusting a few months in, and hearing changes gradually enough that a wearer often won’t notice the fit has drifted without someone else checking.

Who should buy, and who shouldn’t

Someone in the target population — an adult noticing mild-to-moderate, roughly symmetric hearing decline, comfortable running a phone-based self-test, and put off by the cost or hassle of a full clinical pathway — is well served by this category, and the earbud-adjacent form factor makes daily wear far less stigmatised than a visibly clinical hearing aid ever was, a genuine social win alongside the practical one. Anyone with asymmetric hearing loss, a sudden change in hearing, ringing or pain alongside the loss, or simply uncertainty about the cause should see a GP or audiologist before buying anything in this category, OTC or otherwise, because those symptoms sit outside what any self-fitted device is designed or licensed to address. Readers weighing this category against more conventional earbuds worth wearing all day should also read The Best Wireless Earbuds Under £100: What the Money Actually Buys, and anyone specifically comparing all-day open-style comfort should see Open-Ear Earbuds for Running: The Promise vs the Wind Noise for how a different all-day earbud category handles the same comfort-over-hours problem.

The verdict

Buy — for the specific, FDA-defined population this category exists for, and with a realistic sense of what a self-fitted device can and can’t correct for. It’s worth the money at OTC pricing for straightforward, mild-to-moderate, roughly symmetric hearing loss, and the earbud-like form factor is a genuine, underrated win for anyone who’d otherwise avoid a visibly clinical hearing aid. It stops being worth it the moment a buyer’s hearing loss is asymmetric, severe, sudden, or accompanied by other symptoms — that buyer should see a GP or audiologist first, full stop, because no self-test replaces a proper diagnosis. Wait rather than buy immediately if a specific model’s Bluetooth and app reviews show recent reliability complaints; this category is still young enough that a firmware generation can matter, and checking recent rather than launch-era reviews is worth the delay.